20 Years ECA Academy

From 6-7 June 2019 in Heidelberg, Germany

Join us and celebrate the 20 years anniversary of ECA in Heidelberg at the 8th European GMP Conference
- Meet speakers from US FDA, EU GMP Inspectorates and Pharmaceutical Industry to hear the latest GMP Trends
- Receive the latest ECA Guidance Documents at no costs!

Find out more

Acknowledged GMP/GDP Certification

Highly qualified personnel is crucial in the pharmaceutical industry. The ECA Certification scheme with 14 continuous education programmes trains you adequately.

Read more

GMP/GDP Training Matrix

GMP/GDP Training Matrix

Are you looking for certain GMP/GDP Training Courses? The GMP/GDP Matrix will help you find your training course.

Find out more

ECA – Your GMP/GDP Information Source

With news, trainings and conferences, a comprehensive guidelines database, publications and more the ECA is the leading European training and information services provider in the GMP and GDP environment.

Read more

Latest GMP News

May 16

GDP-Inspector: Why Supplier Qualification is important ...

The MHRA explains in a Blog what supplier qualification means and why it is necessary to do it comprehensively.

More

May 16

New office-based GDP-Inspection Process in UK ...

The U.K. Medicines and Health Products Agency (MHRA) is testing a new, office-based GDP-Inspection process - without a visit of the site. 

More

May 15

Warning Letter on Data Integrity Issues in the Microbiological Laboratory ...

Among other things, insufficient or missing reports of test results in a microbiological laboratory resulted in a Warning Letter addressed to the company concerned. Read more about the Warning Letter to Hospira Healthcare India Pvt.

More

May 15

How does the GDPR impact Clinical Trials? ...

The European Commission released a Question and Answers paper on the interplay between the Clinical Trials Regulation (CTR) and the General Data Protection Regulation (GDPR).

More

May 15

Numerous GMP Deviations found at US Manufacturing Site ...

Due to the deficiencies discovered during an inspection performed in July 2018, the US FDA has now issued a Warning Letter to a US pharmaceutical manufacturer of homeopathic drug products. Microbiological impurities in the products and the water used to manufacture the medicinal products are an essential aspect of the complaint.

More

May 08

MRA EU - FDA has approved two more countries ...

With the Mutual Recognition Agreement between Europe and the USA, inspections are to be mutually recognised in the future. The FDA's approval of the EU Member States proceeds successively. Two more countries have recently been approved.

More

GMP Newsletter

Sign up for the free of charge newsletters.

Sign up now!

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK